“We’ve made it very clear that when GSA makes a determination, we will ensure complete, cooperative professional transitions and planning,” Azar said at a briefing. “We follow the guidance. We’re about getting vaccines and therapeutics invented and get the clinical trial data and saving lives here. That’s where our focus is as we go forward with our efforts.”
Azar was referring to a process known as “ascertainment,” a routine recognition by the GSA in the face of a clear presidential victory that would allow the official transition to begin. But although major news networks called the election for Biden nearly two weeks ago, President Donald Trump’s campaign has launched long-shot legal challenges in several states, even though they have little chance of overturning the results.
It’s not clear how widely the instructions were disseminated at the department, and HHS referred a request for comment to the GSA. A spokesperson for the agency described the instructions as routine and said the direction is “given for every transition prior to an ascertainment.”
Biden criticized the Trump administration on Wednesday for not officially declaring him the winner, and warned that vaccine distribution could lag as a result of his transition team not being able to work with the administration.
“Soon, we’re going to be behind by weeks and months being able to put together the whole initiative relating to the biggest promise we have with two drug companies coming along and finding 95% effectiveness, efficiency in the vaccines, which is enormous promise,” he said.
Adm. Brett Giroir, the assistant secretary for health at HHS, told CNN’s Erin Burnett on “OutFront” Wednesday evening that the HHS guidance regarding the Biden transition team is just “the rule” until there’s ascertainment.
“I don’t make the rules,” he said. “We all want to be transparent.”
Giroir added that regardless of the circumstances, “there is going to be no delay in vaccine distribution.”
“I want to assure Americans — and to the degree that I can, assure Biden’s transition team — that we don’t expect any loss of months or weeks or even a day,” he said. “Remember, almost all the people working on these teams are career officials. They are not going to go away.”
Still, some leading health experts, including Dr. Anthony Fauci, have emphasized the need for greater cooperation between the Trump administration and Biden’s team. Co-chairs for the President-elect’s Covid-19 advisory board have stressed that their lack of real-time access to data and information on the supply of therapeutics, testing supplies, personal protective equipment, ventilators, hospital bed capacity or the Strategic National Stockpile is hampering their efforts.
“We haven’t been able to sit down with the Trump administration at all, to be able to understand what plans are already in place, where the gaps are, where help is needed, and how we can make sure there’s a smooth hand-off after January 20, where the bulk of these vaccines will be administered after that date,” Dr. Rick Bright, a member of Biden’s Covid-19 Advisory Board, told CNN’s John Berman on “New Day” Wednesday.
Trump has repeatedly refused to recognize his election loss, even though Biden won by the same margin in the Electoral College that the President did four years ago and handily won the popular vote. Trump’s administration has so far refused to cooperate in other areas, including national security, where Biden has been blocked from receiving intelligence briefings that are customary during a transition.
This story has been updated with comments from HHS official Adm. Brett Giroir.
CNN’s Jacqueline Howard, Paul LeBlanc and Naomi Thomas contributed to this report.